Sanofi UK and Royal Berkshire NHS Foundation Trust Optimize Clinical Trial Recruitment with Technology-Driven Feasibility and Site Selection Process

Sanofi UK partnered with Royal Berkshire NHS Foundation Trust to improve clinical trial recruitment using TriNetX. The page states investigators often lack access to comprehensive data on their own patient populations, and that reliance on a network of previously known sites limited the ability to engage broader potential trial sites. TriNetX's technology-driven feasibility and site-selection process was used to address these obstacles. The landing page does not disclose specific quantitative outcomes; it directs readers to a downloadable case study for full results.

TriNetX is a federated real-world-data network where data stays behind each health system's firewall and is queried in place, used for cohort discovery and trial-site feasibility.

This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.